Table: Fuso Pharmaceutical -2023/24 parent results

Fuso Pharmaceutical Industries

10/05/2024 05:40

May 10 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           55.41           51.02          57.00        28.20    
               (+8.6 pct)      (+2.8 pct)     (+2.9 pct)    (+2.8 pct) 
  Operating        1.96            2.21           2.60         1.30    
               (-11.0 pct)     (+14.7 pct)    (+32.4 pct)  (+18.2 pct) 
  Recurring        1.87            2.22           2.30         1.00    
               (-15.7 pct)     (+11.0 pct)    (+23.1 pct)   (-8.9 pct) 
  Net              1.38            1.61           1.70       700 mln   
               (-14.2 pct)     (+8.3 pct)     (+23.4 pct)   (-2.4 pct) 
  EPS          159.98 yen      183.07 yen     197.43 yen    81.30 yen  
  Ann Div       70.00 yen       70.00 yen      80.00 yen               
  -Q2 Div       35.00 yen       30.00 yen      40.00 yen               
  -Q4 Div       35.00 yen       40.00 yen      40.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T